重度子痫前期的生物标志物预测
Biomarker Prediction of Preeclampsia With Severe Features.
出版信息
Obstet Gynecol. 2024 Apr 3. doi: 10.1097/AOG.0000000000005576.
PMID:38569186
Abstract
This Clinical Practice Update provides guidance for the use of a biomarker immunoassay to aid in the risk assessment of certain pregnant women hospitalized for hypertensive disorders for the progression to preeclampsia with severe features. This document updates Practice Bulletin No. 222, Gestational Hypertension and Preeclampsia(Obstet Gynecol 2020;135:e237-60).
摘要
本临床实践更新为使用生物标志物免疫测定法提供指导，以帮助评估因高血压疾病住院的某些孕妇发展为重度子痫前期的风险。本文档更新了第222号实践公告《妊娠期高血压和子痫前期》（《妇产科杂志》2020年；135：e237 - 60）。
Zotero 插件